发明名称 USE OF LEFLUNOMID FOR THE INHIBITION OF TUMOR NECROSIS FACTOR ALPHA.
摘要 <p>N-(4-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide is an effective compound for preventing and treating diseases in which tumour necrosis factor alpha is involved. It is used as pharmaceutical.</p>
申请公布号 GR3029490(T3) 申请公布日期 1999.05.28
申请号 GR19990400586T 申请日期 1999.02.25
申请人 HOECHST AKTIENGESELLSCHAFT 发明人 WEITHMANN, KLAUS ULRICH, DR.;BARTLETT, ROBERT RYDER, DR.
分类号 A61K31/42;A61P9/00;A61P11/00;A61P31/12;A61P31/18;A61P33/02;A61P35/00;A61P43/00;C07D261/18;(IPC1-7):A61K31/42 主分类号 A61K31/42
代理机构 代理人
主权项
地址